The buyers or most likely investors will arrive soon enough and in numbers once a suitable deal is done with Amgen and a clear funded pathway to commercialisation and revenue can be seen and with a giant of the pharma industry as a cornerstone investor. When the deal is done nothing will be the same again for many reasons.
The buyers or most likely investors will arrive soon enough and...
Add to My Watchlist
What is My Watchlist?